Redhill Biopharma Ltd. - American Depositary Shares (RDHL) closed at $0.42 on October 23, 2026, up 0.3% from the previous close, on volume of 103,374 shares (30-day average 663,923).
Data as of October 23, 2026.
RedHill Biopharma Regains Global Rights to RHB-102 After Hyloris Deal Termination
TipRanks (Wed, 21-Oct 7:27 AM ET)
PRNewswire (Mon, 19-Oct 8:01 AM ET)
Small Caps Test Their 200-Day Line as Yields Grind Higher and Earnings Season Stirs
Globe Newswire (Thu, 1-Oct 6:24 PM ET)
RedHill Biopharma Announces Operational Highlights and First Half 2026 Financial Results
PRNewswire (Wed, 30-Sep 4:05 PM ET)
Globe Newswire (Tue, 1-Sep 7:00 AM ET)
PRNewswire (Mon, 31-Aug 7:00 AM ET)
Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
PRNewswire (Tue, 28-Jul 7:00 AM ET)
RedHill’s RHB-102 Targets Major GLP-1 Market Challenge: Phase 2 Study Planned for GI Side Effects
Market Chameleon (Mon, 5-Jan 5:33 AM ET)
RDHL Strikes $4 Million Partnership to Accelerate Talicia Sales and Bolster Nasdaq Compliance
Market Chameleon (Mon, 20-Oct 5:53 AM ET)
RedHill Secures $10 Million Court Win—What Does This Mean for the Biopharma’s Outlook?
Market Chameleon (Mon, 29-Sep 5:56 AM ET)
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.
Redhill Biopharma Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol RDHL.
As of October 26, 2026, RDHL stock price declined to $0.41 with 61,261 million shares trading.
RDHL has a beta of 0.95, meaning it tends to be less sensitive to market movements. RDHL has a correlation of 0.03 to the broad based SPY ETF.
RDHL has a market cap of $3.64 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, RDHL traded as high as $12.50 and as low as $.28.
RDHL has underperformed the market in the last year with a price return of -76.3% while the SPY ETF gained +15.3%. RDHL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.6% and -23.9%, respectively, while the SPY returned +4.1% and -1.5%, respectively.
RDHL support price is $.40 and resistance is $.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RDHL shares will trade within this expected range on the day.
